Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Auton Neurosci. 2021 Jun 24;235:102834. doi: 10.1016/j.autneu.2021.102834

Figure 1.

Figure 1.

Original recordings of resting muscle sympathetic nerve activity (MSNA) at baseline and after two months of treatment with sacubitril-valsartan in all patients with heart failure with reduced ejection fraction (n = 9).